The difference in the speed of recovery of CMV-specific CD8+ T cell numbers and their functional and cytolytic activities between patients suggest that one patient might have recovered immunity against CMV infection much earlier that the other one. This evidence concerns the gene CD8A and cytomegalovirus infection.